BBVA USA’s Clorox CLX Stock Holding History

BBVA USA’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$228K	Buy	1,376 +37	+3%	+$6.37K	0.01%	422
2021 Q2	$241K	Buy	+1,339	New	+$244K	0.01%	436

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BBVA USA's CLX Position: Q3 2021 in Review

BBVA USA increased its Clorox (CLX) stake by 2.8% in Q3 2021, buying an estimated $6.37K and bringing the position to 1,376 shares worth $228K. The position accounts for 0.01% of the portfolio, ranked #422.

BBVA USA first reported a position in CLX in Q2 2021 and has held it in 2 quarters since. The position peaked at $241K in Q2 2021. 1,134 funds tracked by Wall St. Rank hold CLX as of Q3 2021.

BBVA USA held 1,376 shares of Clorox worth $228K as of Q3 2021.
BBVA USA bought 37 Clorox shares in Q3 2021, an estimated $6.37K.
Clorox made up 0.01% of BBVA USA's portfolio in Q3 2021, its #422 holding.
BBVA USA first reported a position in Clorox in Q2 2021 and has held it in 2 quarters since.
BBVA USA's Clorox position peaked at $241K in Q2 2021.
1,134 funds tracked by Wall St. Rank held Clorox as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.